Global Issues in Pharmaceutical Marketing
Routledge (Verlag)
978-0-415-89532-3 (ISBN)
Global Issues in Pharmaceutical Marketing presents a balanced, research-based perspective combined with a practical outlook on the current issues faced by the ethical, biotech, and generic segments of the pharmaceutical industry. It integrates an analytical approach with a global view to examine such issues as market access, digital marketing, emerging markets, branding, and more. The book covers not only the North American and Western European markets, but focuses on non-Western markets, such as Latin America and Asia. Each chapter is written as an individual essay about a given issue, and where relevant, original cases are provided to illustrate how these issues are currently managed by the global industry.
This book offers a thoughtful and thorough description of the industry’s current situation and integrates the latest scholarly and industry research from different disciplines in one place for convenient reference. It may be used in the following ways:
To stimulate class discussions and inspire new streams of research for academics and graduate students;
To introduce the industry to those interested in a career, to orient new industry hires, or to provide experienced practitioners with current research that will enhance their knowledge;
To provide an understanding of the industry for those in the healthcare sector, such as physicians, pharmacists, as well as medical and pharmacy students; and
To present recent and relevant research for those in government, public or private payers, and public policy environments to facilitate their decision making.
This book will prove to be a useful resource and an important source of information for academics and their students, professionals, and policymakers around the world.
Lea Prevel Katsanis is a Professor in the Department of Marketing at the John Molson School of Business, Concordia University, Canada. Prior to her academic career, she worked in the US, international, and subsidiary operations of three global pharmaceutical companies. She has published numerous articles in outlets, such as the International Journal of Pharmaceutical and Healthcare Marketing, Health Marketing Quarterly, Journal of Product and Brand Management, Journal of Consumer Marketing, and International Marketing Review.
1. Pharmaceutical Industry Structure: Its Effect on Marketing Performance and Product Innovation 2. The Environmental Forces that Influence Industry Stakeholders and Shape their Interactions 3. Global Health Care Systems and Market Access: Variations on a Theme 4. The Structure of the Global Marketing Organization and its Effect on Market Performance 5. Global Pharmaceutical Branding: Moving from Blockbuster to Niche Strategies 6. Traditional Industry Communication to Physicians: Promotional and and Informational Elements 7. Digital Communication to Physicians: Closed Loop and Multichannel Marketing 8. Direct to Consumer Advertising: Broadcast and Print Media 9. Consumer Digital Communication Channels: eDTCA 1.0, 2.0 and mHealth 10. Industry Self Regulation: Finding the Balance 11. Emerging Markets and OTC Markets: Future Opportunities and Current Challenges 12. The Industry’s Declining Reputation: A Prescription for Change
| Zusatzinfo | 16 Tables, black and white |
|---|---|
| Verlagsort | London |
| Sprache | englisch |
| Maße | 203 x 254 mm |
| Gewicht | 408 g |
| Themenwelt | Medizin / Pharmazie ► Pharmazie |
| Technik | |
| Wirtschaft ► Betriebswirtschaft / Management ► Marketing / Vertrieb | |
| Wirtschaft ► Volkswirtschaftslehre | |
| ISBN-10 | 0-415-89532-4 / 0415895324 |
| ISBN-13 | 978-0-415-89532-3 / 9780415895323 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
